David Silberman
Förmögenhet: 117 700 $ per 2026-06-30
Förmögenhet: 117 700 $ per 2026-06-30
David Silberman currently works at Nasus Pharma Ltd., as Director from 2025 and Compugen Ltd., as Chief Financial Officer from 2024.
Mr. Silberman also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Manager-Global Internal Audit from 2018 to 2021 and Oramed Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer from 2021 to 2022.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
COMPUGEN LTD. 0,06 % | 2026-07-29 | 55 000 ( 0,06 % ) | 117 700 $ | 2026-06-30 |
NASUS PHARMA LTD. -.--% | 2026-03-25 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| COMPUGEN LTD. | Finansdirektör/CFO | 2024-08-15 |
| NASUS PHARMA LTD. | Direktör/Styrelseledamot | 2025-08-11 |
| Företag | Position | Slut |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Finansdirektör/CFO | 2022-01-09 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Comptroller/Controller/Revisor | 2021-05-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Oramed Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån